Deutsche High Income Trust (NYSE: KHI) (the “Fund”) announced today that
a proposal to convert the Fund from a closed-end investment company to
an open-end investment company will be presented at a meeting of
shareholders of the Fund to be held in 2015.
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company
that develops and sells high performance liquid purification
ultrafilters and an on-line mid-dilution hemodiafiltration system for
use with a hemodialysis machine for the treatment of chronic renal
failure patients, today announced that the Company's Board of Directors
has appointed Paul A.
Generic biotech drugs took one step closer to reality after a Food and Drug Administration advisory panel recommended the agency approve a Novartis AG (NVS) version of Amgen's Inc.'s (AMGN) drug Neupogen, according to media reports late Wednesday.
Generic biotech drugs took one step close to reality after a Food and Drug Administration advisory panel recommended the agency approve a Novartis AG (NVS) version of Amgen's Inc.'s (AMGN) drug Neupogen, according to media reports late Wednesday.
By Jon Kamp and Erin Ailworth
BOSTON--The two largest electric utilities in Massachusetts have backed out of a plan to buy most of the power that was slated to be generated by the proposed Cape Wind turbine project, dealing a potentially serious blow to the long-delayed wind farm off the state's coast.
WD-40 shares under pressure on earnings miss
WD-40 Co.(WDFC)shares were pressured in the extended session Wednesday after the company's quarterly results came in below the Wall Street consensus.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.